Literature DB >> 23306182

GABA levels in the dorsal anterior cingulate cortex associated with difficulty ignoring smoking-related cues in tobacco-dependent volunteers.

Amy C Janes1, John Eric Jensen, Stacey L Farmer, Blaise Deb Frederick, Diego A Pizzagalli, Scott E Lukas.   

Abstract

Substance abusers have difficulty ignoring drug-related cues, which is associated with relapse vulnerability. This 'attentional bias' towards drug cues translates into an inability to ignore drug-related stimuli and may reflect deficits in the brain regions, such as the dorsal anterior cingulate cortex (dACC)-a key region in cognitive control and adaptive decision making. Quantifying relationships between attentional biases to drug cues and dACC neurochemistry could aid in identifying neurobiological mechanisms associated with increased relapse vulnerability precipitated by drug cues. As gamma-aminobutyric acid (GABA) deficits have been linked to impaired cognition and addictive disorders, we hypothesized that reduced GABA in the dACC would be associated with increased attentional biases towards smoking-related cues. We confirmed this hypothesis among nicotine-dependent tobacco smokers by combining an offline behavioral measure of attentional bias with magnetic resonance spectroscopy. Smokers with the greatest attentional bias also experienced more negative affect during early nicotine withdrawal. Findings revealed a relationship between heightened reactivity to drug cues, and both decreasing dACC GABA and early withdrawal symptoms. Because reduced GABA function in frontal brain regions disrupt cognitive function, our findings suggest that smokers with diminished dACC GABA may lack the cognitive resources to successfully ignore highly salient distractors such as tobacco-related stimuli and therefore might be more prone to cue-induced relapse. This newly discovered relationship between dACC GABA and attentional bias provides evidence for a neurochemical target, which may aid smoking cessation in highly cue-reactive individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306182      PMCID: PMC3629395          DOI: 10.1038/npp.2013.10

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  54 in total

1.  Selective processing of smoking-related cues in current smokers, ex-smokers and never-smokers on the modified Stroop task.

Authors:  Marcus Munafò; Karin Mogg; Sarah Roberts; Brendan P Bradley; Michael Murphy
Journal:  J Psychopharmacol       Date:  2003-09       Impact factor: 4.153

2.  Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3 T instrument and its dependence on brain region and the female menstrual cycle.

Authors:  Masafumi Harada; Hitoshi Kubo; Ayumi Nose; Hiromu Nishitani; Tsuyoshi Matsuda
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

3.  Attentional bias predicts outcome in smoking cessation.

Authors:  Andrew J Waters; Saul Shiffman; Michael A Sayette; Jean A Paty; Chad J Gwaltney; Mark H Balabanis
Journal:  Health Psychol       Date:  2003-07       Impact factor: 4.267

4.  Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia.

Authors:  Takeshi Enomoto; Maric T Tse; Stan B Floresco
Journal:  Biol Psychiatry       Date:  2010-12-10       Impact factor: 13.382

5.  Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions.

Authors:  Gary B Kaplan; Kimberly A Leite-Morris; Meenu Joshi; Marwa H Shoeb; Robert J Carey
Journal:  Brain Res       Date:  2003-10-10       Impact factor: 3.252

6.  Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene.

Authors:  Reagan R Wetherill; Kanchana Jagannathan; Falk W Lohoff; Ronald Ehrman; Charles P O'Brien; Anna Rose Childress; Teresa R Franklin
Journal:  Addict Biol       Date:  2012-10-12       Impact factor: 4.280

7.  Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen.

Authors:  Linda J Porrino; Robert E Hampson; Ioan Opris; Samuel A Deadwyler
Journal:  Psychopharmacology (Berl)       Date:  2012-07-27       Impact factor: 4.530

8.  Alcohol-attentional bias and motivational structure as independent predictors of social drinkers' alcohol consumption.

Authors:  Javad Salehi Fadardi; W Miles Cox
Journal:  Drug Alcohol Depend       Date:  2008-05-27       Impact factor: 4.492

Review 9.  Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.

Authors:  Edmund T Rolls; Marco Loh; Gustavo Deco; Georg Winterer
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

10.  The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention.

Authors:  Alan L Pehrson; Corina O Bondi; Nelson K B Totah; Bita Moghaddam
Journal:  Psychopharmacology (Berl)       Date:  2012-07-14       Impact factor: 4.530

View more
  12 in total

1.  Revisiting the role of the insula and smoking cue-reactivity in relapse: A replication and extension of neuroimaging findings.

Authors:  A C Janes; J M Gilman; M Radoman; G Pachas; M Fava; A E Evins
Journal:  Drug Alcohol Depend       Date:  2017-07-12       Impact factor: 4.492

2.  Insula-Dorsal Anterior Cingulate Cortex Coupling is Associated with Enhanced Brain Reactivity to Smoking Cues.

Authors:  Amy C Janes; Stacey Farmer; Alyssa L Peechatka; Blaise de B Frederick; Scott E Lukas
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

3.  Postnatal Cardiovascular Consequences in the Offspring of Pregnant Rats Exposed to Smoking and Smoking Cessation Pharmacotherapies.

Authors:  Kathirvel Gopalakrishnan; Amar S More; Gary D Hankins; Tatiana N Nanovskaya; Sathish Kumar
Journal:  Reprod Sci       Date:  2016-10-12       Impact factor: 3.060

4.  Salience network coupling is linked to both tobacco smoking and symptoms of attention deficit hyperactivity disorder (ADHD).

Authors:  A C Janes; J M Gilman; B B Frederick; M Radoman; G Pachas; M Fava; A E Evins
Journal:  Drug Alcohol Depend       Date:  2017-11-21       Impact factor: 4.492

5.  Dissociable contributions of anterior cingulate cortex and basolateral amygdala on a rodent cost/benefit decision-making task of cognitive effort.

Authors:  Jay G Hosking; Paul J Cocker; Catharine A Winstanley
Journal:  Neuropsychopharmacology       Date:  2014-02-05       Impact factor: 7.853

6.  A role of anterior cingulate cortex in the emergence of worker-parasite relationship.

Authors:  Soyoun Ahn; Yujeong Kang; Jong Won Lee; Se Jin Jeong; Yoo Jin Lee; Soomin Lee; Jeongyeon Kim; Ja Wook Koo; Jeansok J Kim; Min Whan Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

7.  Dorsal anterior cingulate glutamate is associated with engagement of the default mode network during exposure to smoking cues.

Authors:  Amy C Janes; Jennifer Betts; J Eric Jensen; Scott E Lukas
Journal:  Drug Alcohol Depend       Date:  2016-08-09       Impact factor: 4.492

8.  Insula reactivity to negative stimuli is associated with daily cigarette use: A preliminary investigation using the Human Connectome Database.

Authors:  N R Dias; A L Peechatka; A C Janes
Journal:  Drug Alcohol Depend       Date:  2015-12-23       Impact factor: 4.492

Review 9.  Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.

Authors:  Xia Li; Svetlana Semenova; Manoranjan S D'Souza; Astrid K Stoker; Athina Markou
Journal:  Neuropharmacology       Date:  2013-06-07       Impact factor: 5.250

Review 10.  Noninvasive brain stimulation to suppress craving in substance use disorders: Review of human evidence and methodological considerations for future work.

Authors:  Antoine Hone-Blanchet; Domenic A Ciraulo; Alvaro Pascual-Leone; Shirley Fecteau
Journal:  Neurosci Biobehav Rev       Date:  2015-10-09       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.